CLINICAL_TRIALS
trial_result
· 2019-12-20
Clinical Trial Update: Phase II Study of Oral Nafithromycin in CABP [Phase 2]
Summary
Phase II study of oral nafithromycin in community-acquired bacterial pneumonia has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wockhardt | Conditions: Community-Acquired Bacterial Pneumonia (CABP) | Phase 2 | Status: COMPLETED | Results posted: 2019-12-20